why choose us

First received: August 8, 2022

Clinical Trial: Ablation of Hepatocellular Carcinoma: a Nationwide Study

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Hepatocellular Carcinoma
Ablation
Hepatitis C

Study Type: Observational


Official Title: Ablation of Hepatocellular Carcinoma: a Nationwide Study

Brief Summary: Background Hepatocellular carcinoma (HCC) is the most common primary malignancy in the liver. Chronic infection with hepatitis C virus (HCV) is a significant risk factor and may be associated with inferior outcome. According to the Danish national guidelines, ablation should be offered patients with early HCC (tumor < 3 cm) in a cirrhotic liver, who are not transplant candidates. However, the effect of size of the HCC tumor and Hepatitis C virus (HCV) as etiology are insufficiently investigated.PurposesInvestigate…

Read more